SOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is the deadliest cancer mainly owing to its proclivity to early metastasis and the lack of effective targeted therapeutic drugs. Hence, understanding the molecular mechanisms underlying early invasion and metastasis by PDAC is imperative for improving patient outcomes. The present study identified that upregulation of TSPAN8 expression in PDAC facilitates metastasis in vivo and in vitro. We found SOX9 as a key transcriptional regulator of TSPAN8 expression in response to EGF stimulation. SOX9 modulation was sufficient to positively regulate endogenous expression of TSPAN8, with concomitant in vitro phenotypic changes such as loss of cell-matrix adherence and increased invasion. Moreover, increased SOX9 and TSPAN8 levels were shown to correlate in human pancreatic cancer specimens and downregulated in vitro by EGFR tyrosine kinase inhibitors. High expression of SOX9 and TSPAN8 has been associated with tumor stage, poor prognosis and poor patient survival in PDAC. In conclusion, this study highlights the importance of the EGF-SOX9-TSPAN8 signaling cascade in the control of PDAC invasion and implies that TSPAN8 may be a promising novel therapeutic target for the treatment of PDAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Notably, SOX9 has been previously identified as a transcription factor regulating TSPAN8 [29], further supporting the robustness of our approach.”
From Rapid and Robust Generation of Homozygous Fluorescent Reporter Knock-In Cell Pools by CRISPR-Cas9 (2025) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rana, S., Claas, C., Kretz, C. C., Nazarenko, I. A., & Zoeller, M. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.10.002 · Cited by 99
RetractedSiegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712 · cited 1×
“Metastasis is the leading cause of mortality and a major driver behind the lethal nature of PDAC [3].”
BackgroundVincent, A., Herman, J., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,586
Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
Guo, W., Keckesova, Z., Donaher, J. L., Shibue, T., Tischler, V., Reinhardt, F., Itzkovitz, S., Noske, A., Zürrer-Härdi, U., Bell, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.008 · Cited by 957
Hemler, M. E. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.111301.153609 · Cited by 831
Kopp, J. L., von Figura, G., Mayes, E., Liu, F.-F., Dubois, C. L., Morris, J. P., Pan, F. C., Akiyama, H., Wright, C. V. E., Jensen, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.025 · Cited by 697 · cited 1×
“Under chronic inflammation, the overexpression of SOX9 induced by epidermal growth factor (EGFR) signaling is indispensable for acinar to ductal metaplasia (ADM) transdifferentiation [41] and for the KRAS-induced initiation of intraepithelial neoplasias [42, 43].”
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Ye, X., Tam, W. L., Shibue, T., Kaygusuz, Y., Reinhardt, F., Ng Eaton, E., & Weinberg, R. A. (2015) · Nature · doi:10.1038/nature14897 · Cited by 694
Pishvaian, M. J., Blais, E. M., Brody, J. R., Lyons, E., DeArbeloa, P., Hendifar, A., Mikhail, S., Chung, V., Sahai, V., Sohal, D. P. S., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30074-7 · Cited by 548
Neural crest development is regulated by the transcription factor Sox9
Cheung, M., & Briscoe, J. (2003) · Development · doi:10.1242/dev.00808 · Cited by 482
Charrin, S., Jouannet, S., Boucheix, C., & Rubinstein, E. (2014) · Journal of Cell Science · doi:10.1242/jcs.154906 · Cited by 426
A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation
Shih, H. P., Kopp, J. L., Sandhu, M., Dubois, C. L., Seymour, P. A., Grapin-Botton, A., & Sander, M. (2012) · Development · doi:10.1242/dev.078634 · Cited by 228
Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
Swartling, F. J., Savov, V., Persson, A. I., Chen, J., Hackett, C. S., Northcott, P. A., Grimmer, M. R., Lau, J., Chesler, L., Perry, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.012 · Cited by 215
TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling
Zhu, R., Gires, O., Zhu, L., Liu, J., Li, J., Yang, H., Ju, G., Huang, J., Ge, W., Chen, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10739-3 · Cited by 188
Self-citationYue, S., Mu, W., Erb, U., & Zöller, M. (2015) · Oncotarget · doi:10.18632/oncotarget.2958 · Cited by 181
Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion
Larsimont, J.-C., Youssef, K. K., Sánchez-Danés, A., Sukumaran, V., Defrance, M., Delatte, B., Liagre, M., Baatsen, P., Marine, J.-C., Lippens, S., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.008 · Cited by 159
Understanding the role of SOX9 in acquired diseases: lessons from development
Pritchett, J. P., Athwal, V. S., Roberts, N. A., Hanley, N. A., & Hanley, K. P. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.12.001 · Cited by 159
Epigenetic Regulation of SOX9 by the NF-κB Signaling Pathway in Pancreatic Cancer Stem Cells
Sun, L., Mathews, L. A., Cabarcas, S. M., Zhang, X., Yang, A., Zhang, Y., Young, M. R., Klarmann, K. D., Keller, J. R., & Farrar, W. L. (2013) · Stem Cells · doi:10.1002/stem.1394 · Cited by 141
Szala, S., Kasai, Y., Steplewski, Z., Rodeck, U., Koprowski, H., & Linnenbach, A. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6833 · Cited by 133
Gesierich, S., Paret, C., Hildebrand, D., Weitz, J., Z’graggen, K., Schmitz-Winnenthal, F. H., Hořejšı́, V., Yoshie, O., Herlyn, D., Ashman, L. K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1935 · Cited by 127
An EGFR-ERK-SOX9 Signaling Cascade Links Urothelial Development and Regeneration to Cancer
Ling, S., Chang, X., Schultz, L., Lee, T. K., Chaux, A., Marchionni, L., Netto, G. J., Sidransky, D., & Berman, D. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3072 · Cited by 121
Sox9 and programming of liver and pancreatic progenitors
Kawaguchi, Y. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66022 · Cited by 120
Luanpitpong, S., Li, J., Manke, A., Brundage, K., Ellis, E., McLaughlin, S. L., Angsutararux, P., Chanthra, N., Voronkova, M., Chen, Y. C., et al. (2016) · Oncogene · doi:10.1038/onc.2015.351 · Cited by 118
Self-citationBlasco, M. T., Navas, C., Martín-Serrano, G., Graña-Castro, O., Lechuga, C. G., Martín-Díaz, L., Djurec, M., Li, J., Morales-Cacho, L., Esteban-Burgos, L., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.002 · Cited by 115
Self-citationChen, N., Singh, G., König, A. O., Liou, G., Störz, P., Zhang, J., Regul, L., Nagarajan, S., Kühnemuth, B., Johnsen, S. A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.033 · Cited by 110
Greco, C., Bralet, M., Ailane, N., Dubart‐Kupperschmitt, A., Rubinstein, E., Naour, F. L., & Boucheix, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4482 · Cited by 99
Cave, D. D., Guida, M. D., Costa, V., Sevillano, M., Ferrante, L., Heeschen, C., Corona, M., Cucciardi, A., & Lonardo, E. (2020) · Oncogene · doi:10.1038/s41388-020-1289-1 · Cited by 97
Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer‐initiating cells
Wang, H., Rana, S., Giese, N., Büchler, M. W., & Zöller, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28044 · Cited by 88
Self-citationChakravarty, G., Moroz, K., Makridakis, N. M., Lloyd, S. A., Galvez, S. E., Canavello, P. R., Lacey, M. R., Agrawal, K. C., & Mondal, D. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010086 · Cited by 86
SOX9 regulates ERBB signalling in pancreatic cancer development
Grimont, A., Pinho, A. V., Cowley, M. J., Augereau, C., Mawson, A., Giry-Laterrière, M., Van den Steen, G., Waddell, N., Pajic, M., Sempoux, C., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307075 · Cited by 84
SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling
Liu, H., Liu, Z., Jiang, B., Peng, R., Ma, Z., & Lu, J. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-015-0647-z · Cited by 72
Context-specific role of SOX9 in NF-Y mediated gene regulation in colorectal cancer cells
Shi, Z., Chiang, C.-I., Labhart, P., Zhao, Y., Yang, J., Mistretta, T.-A., Henning, S. J., Maity, S. N., & Mori-Akiyama, Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv568 · Cited by 71
Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis
Park, C. S., Kim, T.-K., Kim, H. G., Kim, Y., Jeoung, M. H., Lee, W. R., Go, N. K., Heo, K., & Lee, S. (2016) · Oncogene · doi:10.1038/onc.2015.520 · Cited by 71
Yan, S., Shan, X., Chen, K., Liu, Y., Yu, G., Chen, Q., Zeng, T., Zhu, L., Dang, H., Chen, F., et al. (2018) · Gene · doi:10.1016/j.gene.2018.08.038 · Cited by 68
Self-citationEGFR as a Potential Target for the Treatment of Pancreatic Cancer: Dilemma and Controversies
Nedaeinia, R., Avan, A., Manian, M., Salehi, R., & Ghayour-Mobarhan, M. (2014) · Current Drug Targets · doi:10.2174/1389450115666141125123003 · Cited by 62
Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis
Kaushik, G., Seshacharyulu, P., Rauth, S., Nallasamy, P., Rachagani, S., Nimmakayala, R. K., Vengoji, R., Mallya, K. B., Chirravuri‐Venkata, R., Singh, A. B., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01564-w · Cited by 60
SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer
Zhou, H., Qin, Y., Ji, S., Ling, J., Fu, J., Zhuang, Z., Fan, X., Song, L., Yu, X., & Chiao, P. J. (2017) · Oncogene · doi:10.1038/onc.2017.393 · Cited by 58
Chen, T., Li, J., Xu, M., Zhao, Q., Hou, Y., Yao, L., Zhong, Y., Chou, P., Zhang, W., Zhou, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01024-2 · Cited by 57
Self-citationMyc interacts with Max and Miz1 to repress C/EBPδ promoter activity and gene expression
Si, J., Yu, X., Zhang, Y., & DeWille, J. W. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-92 · Cited by 56
Voglstaetter, M., Thomsen, A. R., Nouvel, J., Koch, A., Jank, P., Navarro, E. G., Gainey‐Schleicher, T., Khanduri, R., Groß, A., Rossner, F., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5281 · Cited by 49
NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation
Heßmann, E., Zhang, J., Chen, N., Hasselluhn, M. C., Liou, G., Störz, P., Ellenrieder, V., Billadeau, D. D., & König, A. O. (2015) · Stem Cells International · doi:10.1155/2016/5272498 · Cited by 46
Anami, K., Oue, N., Noguchi, T., Sakamoto, N., Sentani, K., Hayashi, T., Naito, Y., Oo, H. Z., & Yasui, W. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0478-z · Cited by 45
Tang, L., Jin, J., Xu, K., Wang, X., Tang, J., & Guan, X. (2020) · Oncogenesis · doi:10.1038/s41389-020-0232-1 · Cited by 41
Ping-Pong—Tumor and Host in Pancreatic Cancer Progression
Mu, W., Wang, Z., & Zöller, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01359 · Cited by 38
EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
Park, S. J., Gu, M. J., Lee, D., Yun, S. S., Kim, H. J., & Choi, J. H. (2015) · PubMed · Cited by 37
Tetraspanin-8 promotes hepatocellular carcinoma metastasis by increasing ADAM12m expression
Fang, T., Lin, J., Wang, Y., Chen, G., Huang, J., Chen, J., Zhao, Y., Sun, R., Liang, C., & Liu, B. (2016) · Oncotarget · doi:10.18632/oncotarget.9769 · Cited by 36
Giampieri, R., Piva, F., Occhipinti, G., Bittoni, A., Righetti, A., Pagliaretta, S., Murrone, A., Bianchi, F., Amantini, C., Giulietti, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215990 · Cited by 36
Kyuno, D., Zhao, K., Bauer, N., Ryschich, E., & Zöller, M. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.08.021 · Cited by 30
Tspan8-β-catenin positive feedback loop promotes melanoma invasion
Kharbili, M. E., Agaësse, G., Barbollat‐Boutrand, L., Pommier, R. M., de la Fouchardière, A., Larue, L., Caramel, J., Puisieux, A., Berthier‐Vergnes, O., & Masse, I. (2019) · Oncogene · doi:10.1038/s41388-019-0691-z · Cited by 29
Yue, G. G., Lee, J. K.-M., Li, L., Chan, K., Wong, E. C.-W., Chan, J. Y., Fung, K., Lui, V. W. Y., Chiu, P. W. Y., & Lau, C. B. (2015) · PubMed Central · Cited by 27
ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis
Wang, L., Yang, H., Zamperone, A., Diolaiti, D., Palmbos, P. L., Abel, E. V., Purohit, V., Dolgalev, I., Rhim, A. D., Ljungman, M. E., et al. (2019) · Genes & Development · doi:10.1101/gad.323303.118 · Cited by 26
Mu, W., Provaznik, J., Hackert, T., & Zöller, M. (2020) · Cells · doi:10.3390/cells9020319 · Cited by 25
Kim, T., Park, C. S., Jeoung, M. H., Lee, W. R., Go, N. K., Choi, J. R., Lee, T. S., Shim, H., & Lee, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.031 · Cited by 24
p53 targets TSPAN8 to prevent invasion in melanoma cells
Agaësse, G., Barbollat‐Boutrand, L., Kharbili, M. E., Berthier‐Vergnes, O., & Masse, I. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.11 · Cited by 24
Higashihara, T., Yoshitomi, H., Nakata, Y., Kagawa, S., Takano, S., Shimizu, H., Kato, A., Furukawa, K., Ohtsuka, M., & Miyazaki, M. (2017) · Pancreas · doi:10.1097/mpa.0000000000000945 · Cited by 22
Hu, B., Wang, J., & Jin, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.7160 · Cited by 20
Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer
Shi, J., Guo, J., & Li, X. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4201 · Cited by 15
Cited by
Fan, G., Yu, B., Tang, L., Zhu, R., Chen, J., Zhu, Y., Huang, H., Zhou, L., Liu, J., Wang, W., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj5705 · Cited by 128
Self-citationLu, X., An, L., Fan, G., Zang, L., Huang, W., Li, J., Liu, J., Ge, W., Huang, Y., Xu, J., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00628-8 · Cited by 78
Self-citationMa, H., Srivastava, S., Ho, S. W. T., Xu, C., Lian, B. S. X., Ong, X., Tay, S. T., Sheng, T., Lum, H. Y. J., Ghani, S. A. B. A., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0605 · Cited by 78
Liu, W., Yu, X., Yuan, Y., Feng, Y., Wu, C., Huang, C., Xie, P., Li, S., Li, X., Wang, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202206335 · Cited by 41
Tspan protein family: focusing on the occurrence, progression, and treatment of cancer
Zhang, H., Song, Q., Shang, K., Li, Y., Jiang, L., & Yang, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01961-0 · Cited by 40
Metadata
- Authors
- Li, J., Chen, X., Zhu, L., Lao, Z., Zhou, T., Zang, L., Ge, W., Jiang, M., Xu, J., Cao, Y., Du, S., Yu, Y., Fan, G., & Wang, H.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Fan, Guangjian
- Wang, Hongxia
- Venue
- Oncogene
- Published
- 2021-06-23
- Volume
- 40
- Issue
- 30
- Pages
- 4884-4893
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC8321899
- OpenAlex
- W3175827193
- Cited by
- 45
- References
- 59
- Citations by year
- 2026: 2 · 2025: 14 · 2024: 9 · 2023: 9 · 2022: 9 · 2021: 2
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Oncogene (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Shanghai Science and Technology Innovation Action Plan
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- SOX9, TSPAN8, pancreatic ductal adenocarcinoma, metastasis, tumor invasion, EGF signaling, EGFR tyrosine kinase inhibitors, transcriptional regulation, cell-matrix adhesion, therapeutic target
- MeSH terms
- Cell Movement, Disease Susceptibility, Epidermal Growth Factor, Humans, Neoplasm Metastasis, Neoplasm Staging, Pancreatic Neoplasms, Prognosis, Promoter Regions, Genetic, Protein Binding, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Disease Progression, SOX9 Transcription Factor, Tetraspanins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.